Drug Shortage Report for TWYNSTA
| Report ID | 130443 |
| Drug Identification Number | 02371057 |
| Brand name | TWYNSTA |
| Common or Proper name | TWYNSTA 60/10MG 4X7 |
| Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
| Market Status | MARKETED |
| Active Ingredient(s) | TELMISARTAN AMLODIPINE |
| Strength(s) | 80MG 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 4X7 BLISTER PACK |
| ATC code | C09DB |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-12-21 |
| Actual start date | |
| Estimated end date | 2021-01-25 |
| Actual end date | 2021-01-28 |
| Shortage status | Resolved |
| Updated date | 2021-01-29 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
| Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2021-01-29 | French | Compare |
| v4 | 2021-01-29 | English | Compare |
| v3 | 2020-12-22 | English | Compare |
| v2 | 2020-12-18 | French | Compare |
| v1 | 2020-12-18 | English | Compare |
Showing 1 to 5 of 5